AveXis Managed Access Program Cohort for Access to AVXS-101 (Q64123874)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AveXis Managed Access Program Cohort for Access to AVXS-101 |
clinical trial |
Statements
A Managed Access Program (MAP) Cohort Treatment Protocol to Provide AVXS-101 to Patients With a Genetic Diagnosis of Spinal Muscular Atrophy (SMA) With 1, 2 or 3 Copies of SMN2 (English)
0 references